The Liver X Receptor Agonist GW3965 Improves Recovery from Mild Repetitive Traumatic Brain Injury in Mice Partly through Apolipoprotein E

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Namjoshi, Dhananjay R ^a   Martin, Georgina ^a   Donkin, James ^a   Wilkinson, Anna ^a   Stukas, Sophie ^a   Fan, Jianjia ^a   Carr, Michael ^a   Tabarestani, Sepideh ^a   Wuerth, Kelli ^a   Hancock, Robert E W ^a   Wellington, Cheryl L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; ABC TRANSPORTER A1; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; LIVER X RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AXONAL INJURY; COGNITIVE DEFECT; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; DRUG RESPONSE; MALE; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PATTERN RECOGNITION; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; WORKING MEMORY;

AMYLOID BETA-PEPTIDES; ANIMALS; APOLIPOPROTEINS E; ATP-BINDING CASSETTE TRANSPORTERS; AXONS; BENZOATES; BENZYLAMINES; BRAIN INJURIES; COGNITION; CYTOKINES; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; ORPHAN NUCLEAR RECEPTORS; PEPTIDE FRAGMENTS; RECOVERY OF FUNCTION;

MUS;

EID: 84872564252     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053529     Document Type: Article

References (68)

1. Corrigan JD, Selassie AW, Orman JA, (2010) The epidemiology of traumatic brain injury. J Head Trauma Rehabil 25: 72-80.
2. Faul MM, Xu L, Wald MM, Coronado VG (2010) Traumatic brain injury in the united states: emergency department visits, hospitalizations and death 2002-2006. Atlanta: Centres for Disease Conrtol and Prevention.
3. Elder GA, Cristian A, (2009) Blast-related mild traumatic brain injury: mechanisms of injury and impact on clinical care. Mount Sinai J Med 76: 111-118.
4. Werner C, Engelhard K, (2007) Pathophysiology of traumatic brain injury. Br J Anaesth 99: 4-9.
5. Graham DI, McIntosh TK, Maxwell WL, Nicoll JA, (2000) Recent Advances in Neurotrauma. J Neuropathol Exp Neurol 59: 641-651.
6. Ladu MJ, Reardon C, Van Eldik L, Fagan AM, Bu G, et al. (2000) Lipoproteins in the central nervous system. Ann New York Acad Sci 903: 167-175.
7. Laskowitz DT, Horsburgh K, Roses AD, (1998) Apolipoprotein E and the CNS response to injury. J Cereb Blood Flow Metab 18: 465-471.
8. Poirier J, (1994) Apolipoprotein E in animal models of CNS injury and Alzheimer's disease. Trends Neurosci 17: 525-530.
9. Kay AD, Day SP, Kerr M, Nicoll JA, Packard CJ, et al. (2003) Remodeling of cerebrospinal fluid lipoprotein particles after human traumatic brain injury. JNeurotrauma 20: 717-723.
10. Iwata A, Browne KD, Chen XH, Yugushi T, Smith DH, (2005) Traumatic brain injury induces biphasic upregulation of ApoE and ApoJ protein in rats. J Neurosci Res 82: 103-114.
11. Chen Y, Lomnitski L, Michaelson DM, Shohami E, (1997) Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience 80: 1255-1262.
12. Han SH, Chung SY, (2000) Marked hippocampal neuronal damage without motor deficits after mild concussive-like brain injury in apolipoprotein E-deficient mice. Ann N Y Acad Sci 903: 357-365.
13. Hyman BT, Trojanowski JQ, (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56: 1095-1097.
14. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
15. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, et al. (1993) Apolipoprotein E polymorphism and Alzheimer's disease. The Lancet 342: 697-699.
16. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, et al. (1994) Protective effect of apolipoprotein E type 2 for late onset Alzheimer disease. Nat Genet 7: 180-184.
17. Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, et al. (2011) Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med 3: 89ra57.
18. Lichtman SW, Seliger G, Tycko B, Marder K, (2000) Apolipoprotein E and functional recovery from brain injury following postacute rehabilitation. Neurology 55: 1536-1539.
19. Smith C, Graham DI, Murray LS, Stewart J, Nicoll JA, (2006) Association of APOE e4 and cerebrovascular pathology in traumatic brain injury. JNeurolNeurosurgPsychiatry 77: 363-366.
20. Teasdale GM, Nicoll JA, Murray G, Fiddes M, (1997) Association of apolipoprotein E polymorphism with outcome after head injury. The Lancet 350: 1069-1071.
21. Jiang Y, Sun XC, Gui L, Tang WY, Zhen LP, et al. (2008) Lack of association between apolipoprotein E promoters in epsilon-4 carriers and worsening on computed tomography in early stage of traumatic brain injury. Acta Neurochir Suppl 105: 233-236.
22. Pruthi N, Chandramouli BA, Kuttappa TB, Rao SL, Subbakrishna DK, et al. (2010) Apolipoprotein E polymorphism and outcome after mild to moderate traumatic brain injury: a study of patient population in India. Neurol India 58: 264-269.
23. Zhou W, Xu D, Peng X, Zhang Q, Jia J, et al. (2008) Meta-analysis of APOE4 allele and outcomes after traumatic brain injury. J Neurotrauma 25: 279-290.
24. May S, Martin G, Wellington C, (2011) Brain injury and dementia: Is there a connection? J Neurology Neurosci 2: 1-7.
25. Roberts GW, Gentleman SM, Lynch A, Murray L, Landon M, et al. (1994) Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 57: 419-425.
26. Johnson VE, Stewart W, Smith DH, (2012) Widespread tau and amyloid-beta pathology many years after a single traumatic brain injury in humans. Brain Pathol 22: 142-149.
27. Gentleman SM, Nash MJ, Sweeting CJ, Graham DI, Roberts GW, (1993) Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci Lett 160: 139-144.
28. Sherriff FE, Bridges LR, Gentleman SM, Sivaloganathan S, Wilson S, (1994) Markers of axonal injury in post mortem human brain. Acta Neuropathol (Berl) 88: 433-439.
29. Johnson VE, Stewart W, Smith DH, (2010) Traumatic brain injury and amyloid-beta pathology: a link to Alzheimer's disease? Nat Rev Neurosci 11: 361-370.
30. Magnoni S, Esparza TJ, Conte V, Carbonara M, Carrabba G, et al. (2012) Tau elevations in the brain extracellular space correlate with reduced amyloid-beta levels and predict adverse clinical outcomes after severe traumatic brain injury. Brain 135: 1268-1280.
31. Magnoni S, Brody DL, (2010) New perspectives on amyloid-beta dynamics after acute brain injury: moving between experimental approaches and studies in the human brain. Arch Neurol 67: 1068-1073.
32. Schwetye KE, Cirrito JR, Esparza TJ, Mac Donald CL, Holtzman DM, et al. (2010) Traumatic brain injury reduces soluble extracellular amyloid-β in mice: A methodologically novel combined microdialysis-controlled cortical impact study. Neurobiology of Disease 40: 555-564.
33. Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, et al. (2004) ABCA1 is required for normal CNS apoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem 279 40987-40993.
34. Hirsch-Reinshagen V, Zhou S, Burgess BL, Bernier L, McIsaac SA, et al. (2004) Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J Biol Chem 279: 41197-41207.
35. Hirsch-Reinshagen V, Maia LF, Burgess BL, Blain JF, Naus KE, et al. (2005) The absence of ABCA1 decreases soluble apoE levels but does not diminish amyloid deposition in two murine models of Alzheimer's Disease. J Biol Chem 280: 43243-43256.
36. Koldamova R, Staufenbiel M, Lefterov I, (2005) Lack of ABCA1 considerably decreased brain apoE level and increases amyloid deposition in APP23 mice. J Biol Chem 280: 43224-43235.
37. Wahrle S, Jiang H, Parsadanian M, Hartman RE, Bales KR, et al. (2005) Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease. J Biol Chem 280 43236-43242.
38. Wahrle SE, Jiang H, Parsadanian M, Kim J, Li A, et al. (2008) Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J Clin Invest 118: 671-682.
39. Wojcicka G, Jamroz-Wisniewska A, Horoszewicz K, Beltowski J, (2007) Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism. Postepy Hig Med Dosw (Online) 61: 736-759.
40. Jamroz-Wisniewska A, W¢jcicka G, Horoszewicz K, Beltowski J, (2007) Liver X receptors (LXRs). Part II: Non-lipid effects, role in pathology, and therapeutic implications. Postepy Hig Med Dosw (Online) 61: 760-785.
41. Zelcer N, Khanlou N, Clare R, Jiang Q, Reed-Geaghan EG, et al. (2007) Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proc Natl Acad Sci U S A 104: 10601-10606.
42. Donkin JJ, Stukas S, Hirsch-Reinshagen V, Namjoshi D, Wilkinson A, et al. (2010) ATP-binding cassette transporter A1 mediates the beneficial effects of the liver-X-receptor agonist GW3965 on object recognition memory and amyloid burden in APP/PS1 mice. J Biol Chem 285: 34144-34154.
43. Fitz NF, Cronican A, Pham T, Fogg A, Fauq AH, et al. (2010) Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice. J Neurosci 30: 6862-6872.
44. Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, et al. (2008) ApoE promotes the proteolytic degradation of Abeta. Neuron 58: 681-693.
45. Loane DL, Washington PM, Vardanian L, Pocivavsek A, Hoe HS, et al. (2011) Modulation of ABCA1 by an LXR agonist reduces beta-amyloid levels and improves outcome after traumatic brain injury. J Neurotrauma 28: 225-236.
46. Decuypere M, Klimo P, Jr. (2012) Spectrum of traumatic brain injury from mild to severe. Surg Clin North Am 92: 939-957, ix.
47. Gavett BE, Stern RA, McKee AC, (2011) Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma. Clin Sports Med 30: 179-188.
48. Antunes M, Biala G, (2012) The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 13: 93-110.
49. Loane DJ, Pocivavasek A, Moussa CE, Thompson R, Matsuoka Y, et al. (2009) Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Nat Med 15: 377-379.
50. Tran HT, LaFerla FM, Holtzman DM, Brody DL, (2011) Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities. J Neurosci 31: 9513-9525.
51. Tran HT, Sanchez L, Esperza TJ, Brody DL, (2011) Distint temporal and anatomical distributions of amyloid-β and tau abnormalities following controlled cortical impact in transgenic mice. PLoS One 6: e2575.
52. Tang YP, Noda Y, Hasegawa T, Nabeshima T, (1997) A concussive-like brain injury model in mice (I): impairment in learning and memory. J Neurotrauma 14: 851-862.
53. DeFord SM, Wilson MS, Rice AC, Clausen T, Rice LK, et al. (2002) Repeated mild brain injuries result in cognitive impairment in B6C3F1 mice. J Neurotrauma 19: 427-438.
54. Creeley CE, Wozniak DF, Bayly PV, Olney JW, Lewis LM, (2004) Multiple episodes of mild traumatic brain injury result in impaired cognitive performance in mice. Acad Emerg Med 11: 809-819.
55. Zohar O, Rubovitch V, Milman A, Schreiber S, Pick CG, (2011) Behavioral consequences of minimal traumatic brain injury in mice. Acta Neurobiol Exp (Wars) 71: 36-45.
56. Pan W, Kastin AJ, Rigai T, McLay R, Pick CG, (2003) Increased hippocampal uptake of tumor necrosis factor alpha and behavioral changes in mice. Exp Brain Res 149: 195-199.
57. Tsenter J, Beni-Adani L, Assaf Y, Alexandrovich AG, Trembovler V, et al. (2008) Dynamic changes in the recovery after traumatic brain injury in mice: effect of injury severity on T2-weighted MRI abnormalities, and motor and cognitive functions. J Neurotrauma 25: 324-333.
58. Shitaka Y, Tran HT, Bennet RE, Sanchez L, Levy MA, et al. (2011) Repetitive closed-skull traumatic brain injury in mice causes persistent multifocal axonal injury and microglial reactivity. J Neuropathol Exp Neurol 70: 551-567.
59. Petit-Turcotte C, Aumont N, Blain JF, Poirier J, (2007) Apolipoprotein E receptors and amyloid expression are modulated in an apolipoprotein E-dependent fashion in response to hippocampal deafferentation in rodent. Neuroscience 150: 58-63.
60. Li Y, Zhang L, Kallakuri S, Zhou R, Cavanaugh JM, (2011) Quantitative relationship between axonal injury and mechanical response in a rodent head impact acceleration model. J Neurotrauma 28: 1767-1782.
61. Marmarou A, Foda MA, van den Brink W, Campbell J, Kita H, et al. (1994) A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics. J Neurosurg 80: 291-300.
62. Goldstein LE, Fisher AM, Tagge CA, Zhang XL, Velisek L, et al. (2012) Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med 4: 143ra160.
63. Riddell DR, Zhou H, Comery TA, Kouranova E, Lo CF, et al. (2007) The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease. Mol Cell Neurosci 34: 621-628.
64. Grefhorst A, Elzinga BM, Voshol PJ, Blsch T, Kok T, et al. (2002) Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J Biol Chem 277: 34182-34190.
65. Groot PH, Pearce NJ, Yates JW, Stocker C, Sauermelch C, et al. (2005) Synthetic LXR agonists increase LDL in CETP species. J Lipid Res 46: 2182-2191.
66. Paxinos G, Franklin KBJ (2001) The Mouse Brain In Stereotaxic Coordinates. San Diego: Elsevier/Academic Press.
67. Miao B, Zondlo S, Gibbs S, Cromley D, Hosagrahara BP, et al. (2004) Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator. J Lipid Res 45: 1410-1417.
68. Ennaceur A, Delacour J, (1988) A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res 31: 47-59.